Thursday 27 July 2017

Digital Pathology Market Was Valued USD 350.1 Million In 2016 And Is Expected To Witness A CAGR Of 12.1% During The Forecast Period 2014-2025

Digital Pathology Market is likely to experience an exponential growth by the end of the decade, especially in the regions, such as North America and Europe, where pathologists and medical laboratories are increasingly inclining towards the adoption of these systems. Cloud or Storage as a Service (SaaS) technology-enabled digital pathology is accompanied by key benefits, such as improved connectivity and efficiency, increased productivity, and cost reduction. Incorporation of digital pathology solutions enables accurate, high through put analysis and interpretation of histological images through the use of computer-assisted image analytics, which negate observer variability.

In addition, these technological solutions provide virtual, secure storage options with multi-tenant access to the digital slides. Cloud technology is further facilitating distance consultations between pathologists and physicians globally through the seamless integration of tools, which allow effective information exchange without physical transportation of slides; thus, streamlining the diagnostic analysis process with increased communication between healthcare professionals, which is driving the preference for digital pathology solutions across the globe.

Full Research Report On Global Digital Pathology Market Analysis: 

Additionally, with the advent of Whole Slide Imaging (WSI), the market is anticipated to witness potential growth opportunities and is currently recognized as one of the foremost promising avenues in the field of diagnostic medicine. Reduced human error and improved accuracy attributable to the automated, slide scanning features, and algorithm-facilitated classification of disease conditions are some of the benefits associated with WSI that is presumed to further accelerate the demand in the future. Additionally, the high healthcare expenditure in the field of cancer diagnostics and the surging demand for personalized medicine has triggered the growth of the digital pathology field. The rising need for automation in image-based analytical tools employed for diagnosis is paving the way for the adoption of digital pathology systems.

High Implementation costs and a stringent regulatory framework pose as major hurdles in the incorporation of digital pathology solutions, particularly in the emerging economies. Currently, the digital pathology system is approved by the U.S. FDA for a limited number of applications, which are research-centric. The untapped diagnostic application areas in the U.S. serve as excellent opportunities for the industry players that are worth capitalizing in the near future. For example, in March 2016, Royal Philips entered into a collaborative agreement with Massachusetts General Hospital, wherein the latter is to serve as a testing center to conduct a multi center device precision study involving the former’s digital pathology WSI, IntelliSite Solution. The study is designed to determine the reproducibility of the IntelliSite pathology solution in primary diagnostic use pertinent to the field of cancer.

The digital pathology market is marked by dynamic activities, such as strategic partnerships which are imperative in widening the consumer base. Recently, in June 2016, the Dutch conglomerate, Royal Philips acquired the Irish, PathXL, one of the largest pathology, image-based analysis firms. This acquisition was carried out in order to develop integrated tools targeting applications in computational pathology, workflow solutions, education, and image analytics. Additionally, this acquisition is aimed at underpinning the gradual transition of medical institutions present across the globe from the traditional systems to digitized pathology systems. The aforementioned acquisition will further enable pathologists to perform high throughput analysis of colossal clinical data images sets that are diverse in nature and facilitate improvements in the diagnosis quality; thereby presenting a potential for the inclusion of new therapies and improvements to enhance patient health outcomes.
In 2014, another prominent market player, Objective Pathology formed a partnership with Microscopes International to introduce their new uSCOPEDigital Microscope to the Canadian market for geographical expansion. The future hence looks promising for the digital pathology industry with the sweeping digitization of tools employed in the diagnostics sector revolutionizing the healthcare industry across the globe.

View all related Reports from same Category: 

Grand View Research has segmented the Global Digital Pathology Market on the basis of Technology, Application and Region:

Global Digital Pathology Technology Outlook (Revenue, USD Million, 2012 - 2022)
  • Whole slide Imaging
  • Telepathology
    • Static
    • Dynamic
Global Digital Pathology Application Outlook (Revenue, USD Million, 2012 - 2022)
  • Drug Discovery & Development
  • Academic
  • Disease Diagnosis
Digital Pathology Regional Outlook (Revenue, USD Billion, 2012 - 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • Japan
  • Latin America
    •  Brazil
    • Mexico
  • MEA
  • South Africa
View Press Release Of Digital Signage Market by Grand View Research: http://www.grandviewresearch.com/press-release/global-digital-pathology-market

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit - www.grandviewresearch.com

Dietary Supplements Market Qualitative Analysis By Industry Overview, Trends, Market Drivers And Restraints 2013-2024

Global Dietary Supplements Market is expected to reach USD 278.02 billion by 2024, according to a new report by Grand View Research, Inc. Favourable outlook towards medical nutrition market in light of increasing application for the treatment of malnutrition and cardiovascular disorders is likely to promote the market for dietary supplements.

Rising sales of sports nutrition products in the U.S. and China on account of increasing prevalence of fitness and sports at a domestic level along with new product launches is likely to have a significant impact on the industry over the projected period. The market is expected to generate revenues worth USD 37.16 billion by 2024.

Rising consumption of clinical nutrition products as a prevention medium for reducing malnutrition is expected to have a substantial impact. Furthermore, increasing prevalence of premature births on a global level is expected to promote the use of medicinal supplements over the forecast period. The market was worth USD 19.17 billion in 2015 and is projected to witness growth at a CAGR of 9.5% from 2016 to 2024.

Full Research Report on Global Dietary Supplements Market Analysis: http://www.grandviewresearch.com/industry-analysis/dietary-supplements-market

Further key findings from the report suggest:
  • The market for dietary supplement capsules was valued at USD 26.42 billion in 2015. The increasing use of omega-3 fatty acids in the formulation of dietary supplement capsules is expected to have a positive impact over the forecast period.
  • Amino acid-based dietary supplements accounted for 14.3% of the market share in 2015 and is projected to witness significant growth on account of increasing protein intake by bodybuilders and sports athletes
  • Gel caps and soft gels together accounted for 13.2% of the overall market in 2015. These products are expected to witness growth on account of their increasing application in confectionaries including chocolates, candies, and desserts.
  • Asia Pacific is projected to growth at a CAGR of 11.2% from 2016 to 2024. Rising sales of green juice, royal jelly, blueberries, chlorella, and black vinegar in Japan owing to increasing awareness towards natural products is expected to promote the use of nutritional supplements over the forecast period.
  • North America accounted for 28.5% of the total market in 2015 and is projected to witness growth on account of increasing consumption of products with reduced calorie level and high nutritional content
  • Key participants include Amway Corporation, Pfizer Pharmaceuticals, Abbott Laboratories, Herbalife International, ADM, DuPont, and Carlyle Group. In April 2016, Amway Inc. launched a new sports nutrition energy drink under the brand name, XS Sports Nutrition line. This type of product innovation is expected to force manufacturers to develop new products over the next eight years.

Grand View Research has segmented the Global Dietary Supplements Market by ingredient, product, application, end-use and region:

Ingredient Outlook (Revenue, USD Million, 2013 - 2024)
  • Botanicals
  • Vitamins
  • Minerals
  • Amino Acids
  • Enzymes
  • Others
Product Outlook (Revenue, USD Million, 2013 - 2024)
  • Tablets
  • Capsules
  • Powder
  • Liquids
  • Soft Gels
  • Gel Caps
Application Outlook (Revenue, USD Million, 2013 - 2024)
  • Additional Supplements
  • Medicinal Supplements
  • Sports Nutrition
End-use Outlook (Revenue, USD Million, 2013 - 2024)
  • Infant
  • Children
  • Adults
  • Pregnant Women
  • Old-aged
Regional Outlook (Revenue, USD Million, 2013 - 2024)
North America
  • U.S.
  • Canada
  • Mexico
Europe
  • Germany
  • UK
  • France
  • Italy
Asia Pacific
  • China
  • Japan
  • India
Latin America
  • Brazil
Middle East & Africa (MEA)
  • South Africa
View Press Release of this Report By Grand View Research:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit - www.grandviewresearch.com

Wednesday 26 July 2017

Disposable Syringes Market Report Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors And Trends 2013-2024

Global Disposable Syringes Market is expected to reach a value of USD 9.9 billion by 2024, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising initiatives by government and various NGOs to raise awareness about safe drug delivery to patients in order to avoid transmission of infections and avoid needle stick injuries to healthcare workers, especially in low-income countries.

Organizations such as WHO and UNAIDS are constantly working for this cause. Some of their programs include needle and syringe program and targeted information for drug abusers. The results of these initiatives are evident. For instance, in China, the incidence of HIV/AIDS amongst people who are drug abusers dropped from 2.5 to 0.6 cases per 100 person-years.

Major disposable syringe manufacturers are introducing new products, which is also further augmenting the market growth. In January 2016, Novo Nordisk launched Tresiba, a long-acting insulin degludec injection to treat diabetes. It was initially launched in U.S. and will further target the rest of the market.

Some of the key industry players are Braun Medical, Inc.; Fresenius Kabi AG; Baxter International, Inc.; Terumo Corporation; Novo Nordisk; Covidien; Retractable Technologies, Inc.; and Becton, Dickinson, and Company.

Full Research Report on Global Disposable Syringes Market Analysis:
http://www.grandviewresearch.com/industry-analysis/disposable-syringes-market

Further Key Findings from the Study Suggest:
  • Safety syringes dominated the product segment in 2015 as they provide long-term cost advantage in comparison to the traditional syringes and thus are preferred by healthcare professionals.
  • Therapeutic injections dominated the application segment in 2015 due to the extensive use of injectable drugs in treatment of high prevalence diseases such as HIV, Hepatitis B & C, and diabetes coupled with increasing rate of volunteer blood donations are few reasons for high demand of infusion devices across the globe.
  • Africa does not have established production systems, thus is considered a high potential market.
  • In 2015, North America dominated due to approval of injectable drugs. For instance, in July 2015, the U.S. FDA approved Praluent (alirocumab) which is the first injectable from PCSK9) inhibitors class.
  • The industry has witnessed few major acquisitions. In 2015, Covidien was acquired by Medtronic, Inc in USD 42.9 billion. Moreover, new product development is also on a rise in the industry.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Disposable Syringes Market by type, application and region:

Global Type Outlook (Market revenue in USD Million, 2013 - 2024)
  • Conventional syringes
  • Safety syringes
    • Retractable safety syringes
    • Non-retractable safety syringes
Global Application Outlook (Market revenue in USD Million, 2013 - 2024)
  • Immunization injections
  • Therapeutic injections
Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-disposable-syringes-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Disposable Medical Sensors Market Revenue Was Estimated At USD 3,830 Million In 2013 And Is Expected To Grow At Over 10% From 2014 To 2020

Global Disposable Medical Sensors Market is expected to reach USD 7,543.1 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of HAIs (hospital acquired infections) and government initiatives aimed at reducing central-line associated bloodstream infections and surgical site infections in ward located and ICU patients are expected to serve the market as high impact rendering drivers. Introduction and subsequent rise in usage rates of novel technologies such as cancer tracking sensors, Hba1c sensors and MEMS pressure sensors is expected to boost future market growth.

Strip sensors dominated the overall product segment in terms of revenue and were valued at USD 1,800.2 million in 2013. Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders and the consequent rise in demand for diabetes and cancer biomarkers strip sensors are some factors accounting for its large share.

Full Research Report on Global Disposable Medical Sensors Market Analysis:
http://www.grandviewresearch.com/industry-analysis/disposable-medical-sensors-industry

Further key findings from the study suggest:
  • Image sensors are expected to be a high growth segment over the forecast period owing to the introduction of technology advancements such as optic fiber technology; low power miniature CMOS image sensors and ZSRL image sensors. These sensors enable medical imaging and endoscopy systems to function with accuracy and therefore, help in effective diagnostic and therapeutic interventions.
  • Disposable medical sensors based diagnostic applications dominated the overall market with revenue estimated at over 1,700.0 million in 2013. Increasing demand for point of care diagnoses such as i-stats, biosensors for the diagnosis and monitoring of glucose levels in emergency rooms is expected to drive the market during the forecast period.
  • North America dominated the global market, accounting for over 35% of total revenue in 2013 on account of the presence of sophisticated healthcare infrastructure and growing R&D spending for the development of miniaturized and convenient medical sensors.
  • Asia Pacific disposable medical sensors market is expected to grow at a CAGR of over 11.0% over the next six years, which is the highest among all regions. Increasing demand for home healthcare biosensors and improving healthcare infrastructure in emerging countries such as China and India are some factors contributing to its rapid growth.
  • Some key players of disposable medical sensors include Honeywell International, Inc, Covidien Plc, STMicroelectronics, Given Imaging, Inc., GE Healthcare, Medtronic, Freescale Semiconductor, Inc., Philips Healthcare, Analog Devices, Smiths Medical, Measurement Specialties and Sensirion AG.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Disposable Medical Sensors Market on the basis of product, technology, application and region:

Global Disposable Medical Sensors Product Outlook (Revenue, USD Million, 2012 - 2020)
  • Wearable sensors
  • Implantable sensors
  • Invasive sensors
  • Ingestible sensors
  • Strip sensors
Global Disposable Medical Sensors Technology Outlook (Revenue, USD Million, 2012 - 2020)
  • Temperature sensors
  • Pressure sensors
  • Image sensors
  • Biosensors
  • Accelerometers
  • Others
Global Disposable Medical Sensors Application Outlook (Revenue, USD Million, 2012 - 2020)
  • Diagnostic
  • Patient monitoring
  • Therapeutic
Disposable Medical Sensors Regional Outlook (Revenue, USD Million, 2012 - 2020)
  • North America
  • Europe
  • Asia Pacific
  • RoW

View Press Release Of This Research Report 
By Grand View Research:
 http://www.grandviewresearch.com/press-release/global-disposable-medical-sensors-market              
About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: 
www.grandviewresearch.com

Digital Transformation Market Report Provides Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends 2014-2025

Global Digital Transformation Market is expected to reach USD 798.44 billion by 2025, according to a new study by Grand View Research, Inc. The increasing necessity for the introduction of innovative solutions that are capable of engaging customers or employees to integrate process, data, IT and business and the increasing demand for the adoption of Internet of Things (IoT) are propelling market growth.

Digital transformation allows organizations to tackle disruptive changes such as marketplace fluctuation, and corporate restructuring, among others, occurring in their markets and customer base by designing new products, services, and business models leveraging digitalization. These newly designed solutions are generally a mix of digitally stored historical information about business activities and the customers Furthermore, they facilitate the transformation of traditional processes, business activities, and models to take advantage of the upcoming changes and opportunities of digital technologies.

Moreover, factors such as optimization of end-to-end customer experience and improvement in operational flexibility are promoting the growth of digital transformation along with the recognition of new revenue sources.

Full Research Report On Global Digital Transformation Market Analysis:
http://www.grandviewresearch.com/industry-analysis/digital-transformation-market

Further key findings from the study suggest:
  • The hosted deployment segment is anticipated gain momentum owing to advantages such as convenience, lower cost, and better security. The segment is estimated to grow at a CAGR of 22.3% over the forecast period
  • The healthcare segment is presumed to find the highest growing application and is estimated to grow at CAGR of 19.5% over the next eight years. This can be attributed to the increasing focus of the healthcare providers towards improving the patient care by implementing digital process and technology
  • North America accounted for the largest share in 2016 owing to growing customer interaction through smart devices such as tablets, smartphones, and phablets, among others in this region
  • Furthermore, the presence of leading players such as IBM Corp., CA Technologies, and Hewlett Packard Enterprise Co, among others in the North American region is a key factor contributing to the regional market dominance
  • The Asia Pacific regional market is expected to grow at the highest CAGR over the next eight years. This can be attributed to the growing demand for the application of the Internet of Things.
  • The key industry participants include SAP SE, IBM Corporation, Oracle Corporation, Google Inc., Dell EMC, Hewlett Packard Enterprise Co., CA Technologies, Microsoft Corporation, Adobe Systems Incorporated, Accenture plc, Capgemini Group, Apple Inc., and Kellton Tech Solutions Ltd.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Digital Transformation Market on the basis of type, deployment, enterprise size, end-use, and region:

Type Scope (Revenue, USD Billion; 2014 - 2025)
  • Solution
    • Analytics
    • Cloud Computing
    • Mobility
    • Social Media
    • Others
  • Service
    • Professional Services
    • Implementation & Integration
Deployment Outlook (Revenue, USD Billion; 2014 - 2025)
  • Hosted
  • On-premise
Enterprise Size Outlook (Revenue, USD Billion; 2014 - 2025)
  • Large Enterprise
  • Small and Medium Enterprise
End-use Outlook (Revenue, USD Billion; 2014 - 2025)
  • BFSI
  • Government
  • Healthcare
  • IT & Telecom
  • Manufacturing
  • Retail
  • Others
Regional Outlook (Revenue, USD Billion; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
  • MEA

View Press Release Of This Research Report 
By Grand View Research:
 http://www.grandviewresearch.com/press-release/global-digital-transformation-market             

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: 
www.grandviewresearch.com

Digital Therapeutics Market Report Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors And Trends 2014-2025

Global Digital Therapeutics Market is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. The growth of the market is catapulted by increasing incidences of chronic diseases, increasing emphasis on preventive healthcare, the need to curb healthcare expenditures, and added benefits offered by digital therapeutics. Rise in number of venture capitalists that are investing in the market is another factor that is accelerating its growth. 
Digital therapeutics, commonly known as software-for drugs has been gaining much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient’s vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important benefits offered by digital therapeutics.

With an increase in the internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention. This serves in a discrete and non-interventional manner to persuade individuals to adopt healthier lifestyles and improve physical well-being. Captivating design, extended assessment, and digital tracking are features that are attributing to increasing adoption of digital therapeutics by patients, employers, providers and others.

The North American region contributed to the largest market share owing to technologically advanced medical infrastructure and successful execution of ambulatory health in their healthcare system. Emerging countries like India, China and Brazil are also expected to flourish during the forecast period owing to adoption of enhanced healthcare infrastructure and medical technologies to curb the prevention of chronic diseases.

Full Research Report on Global Digital Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/digital-therapeutics-market

Further Key Findings From the Study Suggest: 
  • The global digital therapeutics market size was estimated at $1.7 Billion in 2016 and is expected to grow at 21.0% CAGR from 2017 to 2025
  • Diabetes is expected to gain the largest market share on the basis of application owing to increasing incidence rates globally and preventive steps taken to reduce them
  • Obesity is also expected to account for a considerable market share due to various healthcare reforms to curb the disease initially and prevent further costs associated with the disease
  • The adoption of digital therapeutics offers reduction in healthcare costs associated with diseases like diabetes and obesity and are thus being used on an increasing scale
  • Digital tracking, continuous monitoring, and management of physical activity and eating habits are factors that are propelling the growth of the market
  • Increasing usage in preventive areas for a wide range of diseases and disorders like respiratory disorders, CVD, and CNS disease are attributes that are bringing about growth of the market
  • Patients accounted for the largest market share in the end-user’s segment owing to user-friendly interface and effective management of diseases
  • The North American region accounted for the highest revenue owing to technological advancement and healthcare expenditure to curb rise in number of chronic diseases
  • The Asia Pacific region is expected to garner considerable growth during the forecast period owing to increasing adoption of advanced healthcare technologies and rise in number of chronic diseases

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Digital Therapeutics Market on the basis of application, end use, and region:

Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others
End-use Outlook (Revenue, USD Million; 2014 - 2025)
  • Patients
  • Providers
  • Payers
  • Employers
  • Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

View Blog On This Research Report By Grand View Research: http://www.grandviewresearch.com/blog/digital-therapeutics-market-size-share             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Smart Electricity Meters Market Report Covers Revenue Forecast, Company Share, Competitive Landscape, Growth Factors, And Trends 2014-2025

Global Smart Electricity Meters Market is anticipated to reach USD 49.9 billion by 2025, according to a new report by Grand View Research, Inc. The rising demand of energy security has been prevailing in the energy sector from a long time.

Renewable energy generation has sufficed this demand to a greater extent, but the energy provided by such systems is intermittent, and thus energy conservation and efficient utilization of energy are the key aspects of energy security. Smart meters deliver instantaneous data which can be analyzed, and the consumption can be controlled stabilizing the energy demands.

The increasing regulatory initiatives to install the smart meters in various regions around the globe is likely to spur the market demand over the forecast period. Smart meters are a fundamental component of a smart grid network. The smart grids are used to monitor and control the transmission system, which is an enhancement over the conventional electrical network. Initialization of smart grids in various regions is expected to fuel the demand for smart meters over the forecast period.

The commercial segment is largely profited by these smart systems as they assist in increasing the energy efficiency by providing real-time pricing and consumption data display which is directly related to the spending of the segment. However, factors, such as electricity theft are likely to restrain the market growth. Smart Electricity Metering mandates have been established for the European Union with rollout plans set by the Commission for Energy Regulation, among other legislative bodies.

Full Research Report on Global Smart Meters market Analysis: http://www.grandviewresearch.com/industry-analysis/smart-meters-market

Further key findings from the report suggest:
  • The growing adoption of smart grids by several regions is anticipated to drive the market
  • The residential segment is expected to portray high growth rate with a CAGR of 5.9% over the projected period.
  • The European regional market is expected to have significant growth over the forecast period, owing to the large-scale adoption of smart meters.
  • The key players in the market include ABB Ltd, General Electric Company, Holley Metering Ltd, Elster Group, Iskraemeco, Itron Inc., Landis+Gyr, Schneider Electric and Siemens AG.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/electronic-devices

Grand View Research has segmented the Global Smart Meters market based on structure, offering, growing mechanism, and regions:

Smart Electricity Meters End Use Outlook (Revenue, USD Million;Volume, Million Units; 2014 - 2025)
  • Residential
  • Commercial
  • Industrial
Smart Electricity Meters Regional Outlook (Revenue, USD Million;Volume, Million Units; 2014 - 2025)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • South Korea
  • South America
    • Brazil
  • The Middle East and Africa (MEA)

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-smart-electricity-meters-market            

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Palm Oil Market Analysis Report Forecasts Revenue And Volume Growth At Global, Regional And Country Levels 2012-2022

In 2014, Global  Palm Oil Market  was valued at USD 61.09 billion.  The market is poised for growth owing to the increasing demand from th...